Oireachtas Joint and Select Committees

Wednesday, 12 July 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion

9:00 am

Professor Michael Barry:

To be assured of meeting the timelines. For me, quality is probably important as well. As I always tell the industry, it is important to have quality people assessing its dossiers, in that it leads to a better outcome and the work is done properly. We have managed to keep to the timelines as much as possible.